Mayo Clinic IBD Biobank



Status:Enrolling by invitation
Conditions:Irritable Bowel Syndrome (IBS), Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - 85
Updated:2/22/2019
Start Date:November 1, 2018
End Date:December 2065

Use our guide to learn which trials are right for you!

Researchers are collecting and storing blood, stool, and urine samples and medical
information to better understand Inflammatory Bowel Disease (IBD) to improve disease outcome.

Subjects will be sent a letter detailing the proposed biobank and soliciting enrollment.
Following the informed consent process, subjects will provide a blood sample (50 ml), urine
sample (50 ml), and stool. The blood and urine samples will either be collected at the one of
the Mayo Clinic outpatient laboratories or by a mail-out kit. Subjects will be asked to
complete a questionnaire and 24-hour food recall questionnaire (completed online).

Inclusion Criteria:

- Patients diagnosed with inflammatory bowel disease (IBD) who are between the ages of
18 and 85 at time of study enrollment.

- The diagnosis of IBD will be based on the standard IBD criteria including biochemical
and colonoscopy screening.

- Women with inflammatory bowel disease of childbearing potential and pregnant women
will be offered enrollment because there is no risk to an unborn child in this
investigation.

- Patients between the ages of 18 and 85 without history of IBD or colon cancer.

Exclusion Criteria:

- Patients with known liver disease.

- Patients unable to provide informed consent.

- Prisoners and institutionalized individuals.

- Patients with a history of colorectal cancer.
We found this trial at
1
site
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials